The Cochrane review reveals inconsistent evidence on neuraminidase inhibitors' efficacy in healthy adults, suggesting gaps in public health data.
Although billions have been spent on oseltamivir in the face of pandemic influenza, the team updating the Cochrane review of neuraminidase inhibitors in healthy adults found that the public evidence base for this global public health drug was fragmented and inconsistent. Peter Doshi tells the story
No takes yet. Share an insight, caveat, or question.
Peter Doshi (2009) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: